Sanjay Misra MD, FSIR, FAHA, FACR (@misramd) 's Twitter Profile
Sanjay Misra MD, FSIR, FAHA, FACR

@misramd

Mayo Clinic Rochester MN, Vascular and Interventional Radiology, Professor, NIH Funded Researcher, and Founder Pavaj Vascular. Husband with three children.

ID: 3188838900

calendar_today08-05-2015 15:26:54

349 Tweet

1,1K Takipçi

279 Takip Edilen

Sanjay Misra MD, FSIR, FAHA, FACR (@misramd) 's Twitter Profile Photo

Recruiting struggles force large hospital to enact a 'drastic reduction' in interventional services healthimaging.com/topics/medical… Sad to see this happen. #patientsafety Society of Interventional Radiology

Sanjay Misra MD, FSIR, FAHA, FACR (@misramd) 's Twitter Profile Photo

Publication alert: jvir.org/article/S1051-… My Lab studies the biology of interventional procedures used every day: PTA. I have been NIH funded for 18 y. If you are interested in being a Physician/Scientist and want to create the cures of tomorrow- DM me. Society of Interventional Radiology Prabh Singh MBBS

Sanjay Misra MD, FSIR, FAHA, FACR (@misramd) 's Twitter Profile Photo

Publication alert: mdpi.com/2306-5354/11/1… New sirolimus coated technologies are using advanced coating technologies. We use this strategy in my lab and believe this is the future. #restenosis #dialysis Pavaj Vascular Society of Interventional Radiology NIH NHLBI NIDDK

Sanjay Misra MD, FSIR, FAHA, FACR (@misramd) 's Twitter Profile Photo

Getting ready for ISET 2025 covering everything from AI to new devices and science. Honored to speak about our experience with AI in CV medicine. kireports.org/cms/10.1016/j.… Barry T. Katzen, MD Tino Peña

Don Garbett (@dongarbettmd) 's Twitter Profile Photo

I have to say that this is a unique opportunity for IR trainees in their last year of training. You get the academic experience in training and some get to see private practice along the way, but few get to see the true outpatient IR experience before they graduate. I'm highly

Radcliffe Vascular (@radcliffevascu) 's Twitter Profile Photo

💡Dr Sanjay Misra MD, FSIR, FAHA, FACR discusses demographic data from the post-market IN.PACT AV Access approval study on the safety and efficacy of the IN.PACT AV #DCB with #paclitaxel treatment for dysfunctional #arteriovenous fistulas and arteriovenous grafts. 📽️👉 ow.ly/wbjj50VHIst #MedEd